Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...

Since the reform of China's drug review and approval in 2015, it has successfully stimulated the enthusiasm of domestic pharmaceutical companies to carry out innovative drug research and development, ...